Advertise | About Us | Contact Us

Article - Issue 63

Beyond Human Intuition

Article - Issue 63

Reimagining Pharmacovigilance

- Issue 63

AI and Computational Modeling Approaches for Dose Optimisation During Drug Development

Article - Issue 63

Reinvent Drug Development and Safety with AI

Article - Issue 63

FROM ALGORITHMS TO BIOLOGY

EDITORIAL SECTIONS

Why X-ray Inspection is a Viable Quality Assurance Solution for Pharma Products

Adopting the Power of AI to Drug Development Projects

A tremendous amount of documentation is created throughout the clinical trial lifecycle

Real-world Evidence

Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA

Just in Time Manufacturing Creating more sustainable supply chains

Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine

Challenges and Advantages of Using Artificial Intelligence in Pharma

Many advanced largescale AI initiatives still need to be proved successful in Pharma

Advisory Board

Victor M. Diaz Perez

Brian D Smith

Nigel Cryer FRSC

Quang Bui

Tamara Miller

Imedla Leslie Rillon

Andri Kusandri

Nicoleta Grecu

Alessio Piccoli

Pramod Kashid

Neil J Campbell

Designing and Developing Green Drug Delivery Systems

Scientist, University of Kansas
Dr Sagar Salave is a Scientist at the University of Kansas USA specializing in mRNALNP therapeutics and viral vaccine formulation With a background in major pharmaceutical MNCs including Lupin and Ciron Drugs he possesses extensive expertise in drug discovery and nanotechnologydriven RD He serves as an Associate Editor for Applied Biochemistry and Biotechnology Journal Springer and sits on the Ed...

Articles

When Orphan Drugs Make All the Difference

Orphan drugs those medications that are typically produced in small quantities for limited patient populations are growing in importance worldwide Once largely considered too costly to produce given the limited number of patients affected by a particular disease new technology and new breakthroughs in biopharma have changed the landscape allowing more orphan dru

Research Insights

Effectiveness Of A Novel Cellular Therapy To Treat Multidrug-resistant Tuberculosis

Abstract Introduction We urgently need novel treatments for multidrugresistant tuberculosis MDRTB Autologous mesenchymal stromal cell MSC infusion is one such possibility due to its potential to repair damaged lung tissue and boost immune responses We aimed to assess the effectiveness of MSC to impro

Case Studies

Solid Form Changes During Drug Development: Good, Bad, And Ugly Case Studies

The relevance of solid form in drug development has been well established over time In order to fully understand drug properties attention has been paid to solid state structure of drug molecules and their relationship to the drug formulation While each drug developer has had their own strategies and workflows for screening and choosing solid forms of drug molecules t...

Techno Trends

AstraZeneca and Roche Announce Strategic Partnership to Advance Oncology Research in Asia

The collaboration aims to enhance oncology research and drug development across Asia

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

Emerging Technologies in Pharmaceutical Sciences

Abhishek Rungta

Abhishek Rungta is the Founder and CEO of INT. (Indus Net Technologies), a full-stack digital transformation company serving 500+ enterprise clients across 45 countries. He writes on enterprise AI adoption, digital transformation, and long-term business building.

Artificial Intelligence in Oncology

Nancy Kapila

Nancy Kapila is a seasoned pharmaceutical consultant with over 5 years of varied experience and a Master’s in Pharmaceutics from Panjab University. She excels in drug mechanisms and interactions. Her career highlights include collaborating with numerous pharmaceutical companies and offering strategic insights and guidance. Nancy stands out for her dedication to keeping abreast of pharmaceutical advancements, regulatory changes, and emerging trends. She believes in continuous learning to navigate the industry’s complexities and provide innovative client solutions. Fascinated by the role of data analytics in decision-making, Nancy delves into data to uncover patterns and opportunities, offering evidence-based recommendations for process optimization, product development, and operational efficiency. Her career is driven by a relentless pursuit of knowledge, passion for data insights, and commitment to leading pharmaceutical companies towards success in a dynamic industry.

Redefining Therapeutics

Mads Hald Andersen

Professor Mads Hald Andersen, DMSc, DScTech, PhD, is Director of the National Center for Cancer Immune Therapy, CCIT-DK, at Copenhagen University Hospital Herlev, Denmark. He discovered tumor microenvironment antigens and anti-regulatory T cells and defined their role in immune regulation. He initiated the immune modulatory vaccine concept and has authored more than 250 publications and 25 patents.

APAC’s Biopharma Providers’ Role in Pioneering a Healthcare Revolution

Narayana Rao

Narayana is responsible for leading the overall business, P&L, strategy, and program management for Avantor’s Biopharma Business Unit in AMEA. He possesses close to two decades of comprehensive experience in international markets, leading diverse teams in account, product, sales and business management, and delivering strategic solutions for Consumables, systems and Instruments in Academic, Pharmaceuticals, Bioprocessing, and Bioresearch Industries.

Tobacco-style Label Warning on Alcohol Products

Dr. M. Aamir Mirza

Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry

INDUSTRY UPDATES

press releasesRead more...

Innovent Biologics announced a strategic collaboration with Eli Lilly on research and development and licensing.

Innovent Biologics SSE HKSE a hightech biopharmaceutical company today announced a strategic collaboration agreement with Eli Lilly and Company for research and licensing focusing on the development of innovative drugs

Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform

Cellares the first Integrated Development and Manufacturing Organization IDMO and Seoul National University Hospital SNUH a leading translational medical center in South Korea today announced a partnership

Zymeworks Completes Acquisition of Theravance Biopharma

Zymeworks Inc Nasdaq ZYME a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today completed

UofG announces second research collaboration with Eli Lilly and Company for immune-related diseases

Worldchanging experts at the University of Glasgow will partner with scientists at leading pharmaceutical company Eli Lilly and Company Lilly to tackle immunerelated diseases

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

Thermo Fisher Scientific the world leader in serving science today announced the Gibco CHOK Catalog Panel a cGMPready portfolio of basal and feed media designed to support strong

Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services

Oracle Life Sciences announced a partnership with Wipro Limited a leading AIpowered technology services and consulting company to strengthen Wipros pharmacovigilance PV service offering using Oracle Life